Skin manifestations of COVID-19: A worldwide review

• Published in: JAAD international Vol. 2; pp. 119 - 133
• Main Authors: Tan, See Wei, Tam, Yew Chong, Oh, Choon Chiat
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2021; Elsevier
• Subjects: acral ischemia; coagulopathy; COVID-19; pseudo-chilblains; rash containing macules and papules; skin manifestations; Systematic Reviews/Meta-Analyses; urticaria; vesicle; COVID-19; acral ischemia; pseudo-chilblains; skin manifestations; urticaria; rash containing macules and papules; vesicle; coagulopathy
• ISSN: 2666-3287; 2666-3287
• DOI: 10.1016/j.jdin.2020.12.003

Because of the increasing emergence of skin manifestations of COVID-19 worldwide, we investigated the published reports of these lesions. We conducted a literature search for original and review articles published from November 11, 2019 to September 30, 2020. We identified 5 skin lesions common in patients with COVID-19: pseudo-chilblains, rashes containing macules and papules, and urticarial, vesicular, and vaso-occlusive lesions. These lesions manifested at various times in relation to the COVID-19 symptoms, which may indicate whether the lesions are virus-induced or are delayed immunological responses to the infection. Skin lesions were more prevalent among Europeans and United States residents than among Asians, as was pseudo-chilblain, and the morphology of the skin lesions varied among continents. Pseudo-chilblains were the most common COVID-19 skin manifestation in Europe and the United States, but there was only 1 reported case from Asian populations. Additionally, patients with vaso-occlusive lesions were more likely than those with pseudo-chilblains to be admitted to the intensive care unit and to die. Different cutaneous manifestations in patients with COVID-19 could reflect a wide spectrum of viral interactions with the skin, though reporting bias may play a role as well.